Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-003826-28Phase 4Terminated
Phase 4 trial of ibuprofen arginine and ibuprofen in osteoarthritis (OA) and hypertension (HTN) (2 arms), sponsored by Zambon. Primary endpoint: Change from baseline in daily spontaneous pain. Started Sep 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-003826-28.